According to the TRICARE Policy Manual, Chapter 6, Section 1.1, Oncotype DX (S3854) is not a covered TRICARE benefit due to the lack of U.S. Food and Drug Administration status. If CPT code S3854 is submitted, the claim will be denied. Providers also should not submit a claim for this with an unlisted code.